Biopharmaceutics

Biopharmaceutics is a branch of pharmaceutics that studies how the properties of a drug, the dosage form, and the route of administration influence the rate and extent of drug absorption into the systemic circulation. It serves as a bridge between pharmaceutical chemistry, formulation science, and pharmacokinetics, with a focus on oral bioavailability and other systemic exposures.

Key concepts include dissolution, which governs how quickly a solid dissolves; permeation across the intestinal mucosa; and first-pass metabolism that can reduce systemic exposure. Drug solubility, permeability, stability, and particle size (including salt form and polymorphism) influence dissolution and absorption. Physiological factors such as gastric pH, gastric emptying time, intestinal transit, bile salts, and whether a dose is taken with food also modulate absorption. The Biopharmaceutics Classification System (BCS) categorizes drugs by solubility and permeability to predict absorption behavior and guide formulation and regulatory decisions. In vitro dissolution testing and in vivo pharmacokinetic studies are used to establish in vitro–in vivo correlations (IVIVC), which relate dissolution profiles to plasma concentrations and support bioequivalence assessments.

Applications include designing oral dosage forms to enhance solubility or permeability, developing modified-release products, and assessing food effects on absorption. Regulatory relevance is significant: demonstrations of comparable systemic exposure drive bioequivalence decisions for generic products, and dissolution testing is a key tool in supporting regulatory approvals.

Biopharmaceutics emphasizes the determinants of absorption and exposure, distinguishing itself from pharmacokinetics, which models drug behavior after absorption within the body.